Advanced glycation end products in children and adolescents with diabetes: Relation to glycemic control and early microvascular complications

Journal of Pediatrics

Volumn 134, Issue 4, 1999, Pages 486-491

  Chiarelli, Francesco ^a   De Martino, Maurizio ^b   Mezzetti, Andrea ^b   Catino, Mariangela ^b   Morgese, Guido ^b   Cuccurullo, Franco ^b   Verrotti, Alberto ^b  

^a Ospedale Policlinico   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT; HEMOGLOBIN A1C; INSULIN;

ADOLESCENT; ADULT; ARTICLE; BLOOD GLUCOSE MONITORING; CHILD; CONTROLLED STUDY; DIABETES CONTROL; DIABETIC MICROANGIOPATHY; DIAGNOSTIC VALUE; FEMALE; HUMAN; IMMUNOFLUORESCENCE TEST; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; ONSET AGE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROLIFERATIVE RETINOPATHY; PUBERTY; RISK;

EID: 0033510738     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-3476(99)70208-8     Document Type: Article

References (21)

1. 1. Brownlee M, Vlassara H, Cerami A. Advanced glycosilation end products in tissue and the biochemical basis of diabetic complications. N Engl J Med 1988;318:1315-21.
2. 2. Makita Z, Radoff S, Rayfield EJ, Yang Z, Skolnik E, Delaney V, et al. Advanced glycosilation end products in patients with diabetic nephropathy. N Engl J Med 1991;325:836-42.
3. 3. McCance DR, Dyer DG, Dunn JA, Bailie KE, Thorpe SR, Baynes JW, et al. Maillard reaction products and their relation to complications in insulin-dependent diabetes mellitus. J Clin Invest 1993;91:2470-8.
4. 4. Beisswenger PJ, Makita Z, Curphey TJ, Moore LL, Jean S, Brinck-Johnsen T, et al. Formation of immunochemical advanced glycosilation end products precedes and correlates with early manifestations of renal and retinal disease in diabetes. Diabetes 1995;44:824-9.
5. 5. Vlassara H, Bucala R. Advanced glycation and diabetes complications: an update. Diabetes Annual/9 1995;227-44.
6. 6. Berg TJ, Bangstad HJ, Torjesen PA, Østerby R, Bucala R, Hanssen KF. Advanced glycation end products in serum predict changes in the kidney morphology of patients with insulin-dependent diabetes mellitus. Metabolism 1997;46:661-6.
7. 7. Berg TJ, Dahl-Jorgensen K, Torjesen PA, Hanssen KF. Increased serum levels of advanced glycation end products (AGEs) in children and adolescents with IDDM. Diabetes Care 1997;20:1006-8.
8. 8. National Diabetes Data Group. Classification of diabetes mellitus and other categories of glucose intolerance. Diabetes 1979;28:1039-57.
9. 9. Makita Z, Vlassara H, Cerami A, Bucala R. Immunochemical detection of advanced glycosilation end products in vivo. J Biol Chem 1992;267:5133-8.
10. 10. Makita Z, Vlassara H, Rayfield E, Cartwright K, Friedman E, Rodby R, et al. Hemoglobin-ACE: a circulating marker of advanced glycosilation. Science 1992;258:651-3.
11. 11. Bucala R, Makita Z, Koschinsky T, Cerami A, Vlassara H. Lipid advanced glycosilation: pathway for lipid oxidation in vivo. Proc Natl Acad Sci USA 1993;90:6434-8.
12. 12. Vlassara H. Recent progress in advanced glycation end products and diabetic complications. Diabetes 1997; 46:S19-S25.
13. 13. Bucala R, Vlassara H. Advanced glycosilation end products in diabetic renal and vascular disease. Am J Kidney Dis 1995;26:875-88.
14. 14. Beisswenger PJ, Moore LL, Brinck-Johnsen T, Curphey TJ. Increased collagen-linked pentosidine levels and advanced glycosilation end products in early diabetic nephropathy. J Clin Invest 1993;92:212-7.
15. 15. Sell DR, Lapolla A, Odetti P, Fogarty J, Monnier VM. Pentosidine formation in skin correlates with severity of complications in individuals with long-standing IDDM. Diabetes 1992;41:1286-92.
16. 16. Hammes H-P, Brownlee M, Edelstein D, Saleck M, Martin S, Federlin K. Aminoguanidine inhibits the development of accelerated diabetic retinopathy in the spontaneous hypertensive rat. Diabetologia 1994;37:32-5.
17. 17. Soulis T, Cooper M, Papazoglou D, Clarke B, Jerums G. Retardation by aminoguanidine of development of albuminuria, mesangial expansion, and tissue fluorescence in streptozotocin-induced diabetic rat. Diabetes 1991;40: 1328-34.
18. 18. Cameron NE, Cotter MA, Dines K, Love A. Effects of aminoguanidine on peripheral nerve function and polyol pathway metabolites in streptozotocin-diabetic rats. Diabetologia 1992;35: 946-50.
19. 19. Horie K, Miyata T, Maeda K, Miyata S, Sugiyama S, Sakai H, et al. Immunohistochemical colocalization of glycoxidation products and lipid peroxidation products in diabetic glomerular lesions. J Clin Invest 1997; 100:2995-3004.
20. 20. Beisswenger PJ, Moore LL, Curphey TJ. Relationship between glycemic control and collagen-linked advanced glycosilation end products in type 1 diabetes. Diabetes Care 1993;16:689-94.
21. 21. Lyons TJ, Bailie KE, Dyer DG, Dunn JA, Baynes JW. Decrease in skin collagen glycation with improved glycemic control in patients with insulin-dependent diabetes mellitus. J Clin Invest 1991;87:1910-5.